Dewi Rahmawati
Universitas Anwar Medika

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

Regulasi Kosmetik Terhadap Izin Edar: A Studi Literature Dewi Rahmawati; Marcelinda Krisdivayanti; Icasia Carolina Dewi; Amelia Saputri Ginting; Tarizza Puspa Anggrelia; Herta Meidya Nurhalita; Laila Sabila Sindriyani; Rosa Virginia Tuda Kou; Kurrota Ayyun; Alfi Dwi Seviah; Nadiya Kamiliya Putri; Yeka Khafidz Ila Rosyidah
Vitamin : Jurnal ilmu Kesehatan Umum Vol. 2 No. 1 (2024): January : Jurnal ilmu Kesehatan Umum
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/vitamin.v2i1.196

Abstract

Cosmetics have varied purposes, including cleansing, increasing brightness, changing appearance, and protecting or maintaining certain conditions. The applicable cosmetics regulations are explained in the BPOM provisions, which mandate registration before cosmetics can be used by consumers. In this research, the results of two literature reviews are presented that support this statement. The first study by (Chandra Adi Gunawan Putra, 2023) shows that the need for state involvement in protecting consumers arises because of the power imbalance between business actors and consumers. The second study by (Ribka Amanda Dera, 2019) the regulation of cosmetic products has been regulated by BPOM number 12 of 2020 article 2 paragraph 1 which emphasizes that cosmetics producers must ensure that their products which will be distributed both domestically and abroad meet the criteria, safety and security standards. benefits, quality marking, and claims. The results of both studies show that the importance of terms and conditions related to cosmetics are under law and regulated in the Republic of Indonesia Constitution, the Health Law, provisions issued by the Minister of Health and decisions taken by the Head of the Republic of Indonesia Food and Drug Supervisory Agency and in BPOM regulations starting from formulation to product withdrawal. So that any party who commits an illegal act by producing or distributing pharmaceutical or cosmetic products without a permit will receive applicable sanctions in accordance with legal provisions.
Pentingnya Izin PIRT Bagi UMKM : Literature Review Articel Dewi Rahmawati; Marthy Meliana; Windi Tri Wahyuni; Ismatun Maulidiyah; Elsa Saqila; Sirojul Eilma; Ni’matul Fauziah; Brelianty Nevy; Miftahul Maulidiyah; Silvia Nur Diana; Annisya San Shabira; Marselinus Seran; Findy Lovirna
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 2 No. 1 (2024): Januari : OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v2i1.193

Abstract

Home Industry Food or what is abbreviated as PIRT, is a certification for industries that produce food and beverages on a home scale. PIRT certification is only given to processed food products with a low level of risk. Home Industry Food (P-IRT) is a distribution permit for home-scale food production. So that consumers (MSMEs) who want to trade or sell no longer need to worry about dosage, product composition and packaging because safety is guaranteed through a P-IRT certificate or halal certificate. The purpose of making this Literature Review Article is to find out about pirt regulations and the importance of pirt permits for a product. The method used in this article is a literature review method with a literature search based on several literature regarding regulations and PIRT certification permits. The results obtained are understanding the regulations that exist in PIRT for MSME products for consumers so that they can guarantee that these products are not illegal and can be trusted in the eyes of the public. In conclusion, from these reviews, it can be concluded that distribution permits and PIRT certificates are mandatory for MSMEs that sell various kinds of products and know the PIRT regulations.
Perlindungan Konsumen terhadap Peredaran Obat Secara Online Tanpa Izin Edar Vina Aprilia; Nur Lailatul Maghfiroh; Salsabila Dhiya Atik; Nabyla Qutrun Nada; Alfan Hermawan; Muhammad Rizky Imami; Moh Basri Firdaus F.N7; Herdiansyah Rusman Hadi; Ainun Nur Cahyani; Marthy Meliana A.J; Dewi Rahmawati
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 2 No. 2 (2024): March : OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v2i2.213

Abstract

Health is the main capital for the growth of the nation's life. The development of trade is currently experiencing very rapidprogress, which occurs not only in the goods traded but also in the buying and selling transactions themselves. One very important component of health is the availability of medicines as part of public health services. This research aims to find out about the distribution of drugs without a distribution permit and consumer protection in terms of monitoring and taking action against drugs without a distribution permit that are sold online by the Food and Drug Supervisory Agency and the Ministry of Communication and Information. The results of the research show that the Food and Drug Supervisory Agency has made various efforts to protect the public from drugs without distribution permits that are sold online, in handling the circulation of drugs sold online, the Food and Drug Supervisory Agency collaborates with Interpol and other government agencies such as the Ministry of Communication and Informatics carries out Operation Pangea. In this operation, the Food and Drug Supervisory Agency will list websites and social media accounts that promote and market drugs without a distribution permit to be submitted to the Ministry of Communication and Information for blocking. A distribution permit is preventive supervision as a form of protection for consumers carried out by the Food and Drug Supervisory Agency before the drug circulates in the community. So it is reasonable to suspect that if a drug does not have a distribution permit, the drug has not been tested for safety, efficacy and quality aspects.